Startup profile for Monogram Health: what they do, why they are interesting, stage (growth), industries, and links to our funding articles. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Monogram Health

Value-based in-home kidney and polychronic care delivery plus benefit management for health plans.

Stage

growth

Status

private

Coverage

full

Overview

Monogram Health is a Nashville value-based specialty provider of in-home evidence-based care and benefit management for patients with polychronic conditions, including chronic kidney disease and ESRD. Founded/incubated with Frist Cressey Ventures in 2019 (Bill Frist chairs the board). Closed $160M Series B led by TPG (2021) and $375M growth capital (Jan 2023) including CVS Health, Cigna Ventures, Humana, Memorial Hermann, SCAN, TPG, Frist Cressey, Heritage Group, Norwest, and others. Operates value-based partnerships across dozens of states.

Why Monogram Health is interesting

Nashville kidney-care scale-up incubated by Frist Cressey Ventures: $375M growth raise (Jan 2023) with CVS, Cigna, Humana, TPG — proof of Middle Tennessee health-services venture density.

Product & use cases

Combines in-home clinical care teams with tech-enabled disease/case management, utilization management, and medication therapy management under value-based contracts with plans and risk-bearing providers.

  • Medicare Advantage and commercial plans managing CKD/ESRD cost and outcomes
  • Slowing kidney disease progression and improving home-based care access
  • Polychronic patients needing coordinated specialty + primary care in-home

Key facts

  • Growth (Jan 2023): $375M with CVS, Cigna Ventures, Humana, TPG, Frist Cressey, Norwest, others
  • Series B (Jun 2021): $160M led by TPG; FCV and Norwest participated
  • Incubated/founded with Frist Cressey Ventures (2019); Bill Frist board chair
  • In-home nephrology + polychronic care model across 30+ states (company materials)

Fundraising history

Growth

2023-01 $375M

Source: https://www.monogramhealth.com/resources/press/monogram-health-closes-375m-growth-capital-raise-to-support-continued-expansion-of-innovative-in-home-kidney-and-polychronic-care-model/

Investors in our directory

Funds linked from Monogram Health's profile — open a fund page for stage focus and related deal articles.

Competitive landscape

Edge: Kidney-specialty VBC operator with plan partnerships and FCV healthcare network — not a pure SaaS navigation layer.

  • Somatus / Strive Health direct

    Value-based kidney care competitors.

  • DaVita / Fresenius care models incumbent

    Dialysis incumbents expanding upstream CKD programs.

  • Generic care management vendors adjacent

    Utilization management without in-home nephrology delivery.

Notable stories

  • FCV frames Monogram as a Nashville success story it incubated — growth capital funded national deployment of in-home kidney and polychronic care (fcventures.com).

Industries

Healthtech

Related funding articles

Venture Capital Tracker pieces that cover Monogram Health's financing or category context.

FAQs about Monogram Health

Practical answers founders, operators, and investors typically search for.

Delivers value-based in-home kidney and polychronic care plus benefit management for health plans.
Frist Cressey Ventures incubated and backed the company; TPG led Series B; 2023 growth included CVS, Cigna, Humana. See /fund/frist-cressey-ventures.
Nashville, Tennessee.
growth
No — private as of July 2026.
January 2023.
healthtech
https://www.monogramhealth.com

Last updated: 2026-07-26